{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:47:04Z","timestamp":1747183624223,"version":"3.40.5"},"reference-count":10,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among multiple myeloma patients. Chang and colleagues' findings indicate that factor Xa inhibitors are as effective as warfarin in preventing VTE without raising the risk of gastrointestinal or intracranial bleeding complications.<\/jats:p><jats:p>Commentary on: Chang et\u00a0al. The comparative efficacy and safety of factor Xa inhibitors and warfarin for primary thromboprophylaxis in multiple myeloma patients undergoing immunomodulatory therapy. Br J Haematol 2024;205:473\u2010477.<\/jats:p>","DOI":"10.1111\/bjh.19640","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:58:47Z","timestamp":1720648727000},"page":"416-417","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u2018X\u2019 marks the spot! Utilising factor Xa inhibitors to optimise thromboprophylaxis in multiple myeloma"],"prefix":"10.1111","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-6694","authenticated-orcid":false,"given":"Thomaz Alexandre","family":"Costa","sequence":"first","affiliation":[{"name":"Department of Medicine University of Colorado School of Medicine  Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-3866","authenticated-orcid":false,"given":"Nicole","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Medicine Federal University of Campina Grande  Campina Grande Para\u00edba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-0585","authenticated-orcid":false,"given":"Joshua","family":"Richter","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"e_1_2_2_2_1","first-page":"1","article-title":"The comparative efficacy and safety of factor Xa inhibitors and warfarin for primary Thromboprophylaxis in multiple myeloma patients undergoing immunomodulatory therapy","volume":"24","author":"Chang YC","year":"2024","journal-title":"Br J Haematol"},{"unstructured":"National Cancer Institute.SEER Cancer Stat Facts: myeloma.2024.https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html","key":"e_1_2_2_3_1"},{"doi-asserted-by":"publisher","key":"e_1_2_2_4_1","DOI":"10.1016\/S0140-6736(21)00135-5"},{"doi-asserted-by":"publisher","key":"e_1_2_2_5_1","DOI":"10.1111\/j.1538-7836.2011.04215.x"},{"doi-asserted-by":"publisher","key":"e_1_2_2_6_1","DOI":"10.3390\/cancers14246216"},{"doi-asserted-by":"publisher","key":"e_1_2_2_7_1","DOI":"10.1016\/S1470-2045(09)70284-0"},{"doi-asserted-by":"publisher","key":"e_1_2_2_8_1","DOI":"10.1111\/bjh.18432"},{"doi-asserted-by":"publisher","key":"e_1_2_2_9_1","DOI":"10.1056\/NEJMoa1814468"},{"doi-asserted-by":"publisher","key":"e_1_2_2_10_1","DOI":"10.1002\/cncr.32724"},{"doi-asserted-by":"publisher","key":"e_1_2_2_11_1","DOI":"10.1001\/jamanetworkopen.2023.25283"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:18:32Z","timestamp":1724739512000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/bjh.19640"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19640","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"2024-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}